Bristol-Myers Squibb News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.05.14	Bristol-Myers, Celldex Announce Clinical Trial Collaboration - Quick Facts (RTTNews)
05.05.14	Bristol-Myers To Present Broad Set Of New Data At 2014 ASCO Annual Meeting (RTTNews)
29.04.14	Bristol-Myers Q1 Profit Tops View, But Revenues Miss; Boosts 2014 EPS Outlook (RTTNews)
29.04.14	Bristol-Myers Q1 Profit Tops Street; Adjusts FY14 Earnings View - Quick Facts (RTTNews)
29.04.14	Bristol-Myers Squibb Buys IPierian For $175 Mln Plus Milestone Payments (RTTNews)
29.04.14	Earnings Watch For April 29 (DWA, EBAY, MAR, STX, TWTR, MGM, BSX) (RTTNews)
14.04.14	Bristol-Myers Submits NDA For Combination Tablet Of Atazanavir With Cobicistat (RTTNews)
10.04.14	Bristol-Myers Squibb Reports Phase III Results From HALLMARK-Dual Trial (RTTNews)
08.04.14	IMMU Chugs Along, MNKD Decision Delayed, QCOR Bought Out, Another First For ISR (RTTNews)
07.04.14	Bristol-Myers Submits NDAs For Daclatasvir And Asunaprevir To FDA (RTTNews)
27.03.14	Pfizer Announces Results Of Pre-specified Subanalysis Of Phase 3 Aristotle Trial (RTTNews)
18.03.14	ATEC Sees Growth, FPRX Gets High-Five, RNA Walks The Talk, RPRX On The Move (RTTNews)
17.03.14	Five Prime And Bristol-Myers Squibb To Collaborate On Immuno-oncology (RTTNews)
17.03.14	IDIX Sues GILD, ICPT Shows POISE, Watch Out For BDSI, SCMP Takes A Hit (RTTNews)
25.02.14	Bristol-Myers Gets FDA Breakthrough Therapy Designation For Hepatitis Drug (RTTNews)
25.02.14	BIOL Has Reason To Smile, CBMG Walks The Talk, CLSN Warms Up, REGN Catches Eyes (RTTNews)
24.02.14	Bristol-Myers Squibb Gets FDA Breakthrough Therapy Designation For Hepatitis C (RTTNews)
03.02.14	AstraZeneca Closes Acquisition Of Bristol's Diabetes Alliance Assets In U.S. (RTTNews)
24.01.14	Bristol-Myers Q4 Results Top View, Confirms Annual EPS Outlook (RTTNews)
24.01.14	Bristol-Myers Q4 Results Top Estimates; Backs FY Non-GAAP EPS View - Quick Facts (RTTNews)
24.01.14	Earnings Watch For January 24 (HON, KMB, PG, XRX, STT, BMY) (RTTNews)
22.01.14	AstraZeneca : Xigduo Gets Approval In EU To Treat Type 2 Diabetes - Quick Facts (RTTNews)
14.01.14	Agenus Initiates Randomized Phase 2 Trial With Prophage For Melanoma (RTTNews)
14.01.14	AstraZeneca Sees 2017 Revenues To Be Broadly In Line With 2013 Revenues (RTTNews)
13.01.14	Portola Enters Second Clinical Collaboration Deal With Bristol-Myers And Pfizer (RTTNews)
13.01.14	AstraZeneca: FDA Approves Farxiga To Treat Type 2 Diabetes (RTTNews)
08.01.14	Bristol-Myers Says Daclatasvir MAA For Chronic Hepatitis C Validated By EMA (RTTNews)
19.12.13	Bristol-Myers To Sell Diabetes Business To AstraZeneca In $4.1 Bln Deal (RTTNews)
19.12.13	Bristol-Myers To Sell Its Global Diabetes Business - Quick Facts (RTTNews)
19.12.13	WSJ: Bristol-Myers Nears $3 Bln Deal To Sell Stake In Diabetes JV To AstraZeneca (RTTNews)
13.12.13	CRMD Awaits Makeover, INSY In Crosshairs, Plandaí On A High, SNTA Enchants (RTTNews)
13.12.13	FDA Panel Oks AstraZeneca, Bristol-Myers Diabetes Drug Dapagliflozin In 2nd Try (RTTNews)
13.12.13	AstraZeneca, Bristol-Myers Say FDA Panel Backs Diabetes Drug Dapagliflozin (RTTNews)
12.12.13	AstraZeneca, Bristol-Myers: FDA Panel Recommends Metreleptin For Generalized LD (RTTNews)
12.12.13	AstraZeneca, Bristol-Myers Squibb Announce FDA's EMDAC Recommends Metreleptin (RTTNews)
22.11.13	AstraZeneca: Xigduo Gets Positive CHMP Opinion For Treatment Of Type 2 Diabetes (RTTNews)
28.10.13	Bristol-Myers, Alder Present Promising Phase IIb Data On Clazakizumab For RA (RTTNews)
26.10.13	Bristol-Myers Reports Long-term Follow-up Results From Study 003 Of Nivolumab (RTTNews)
25.10.13	Bristol-Myers Squibb Prices $1.5 Bln Of Senior Notes (RTTNews)
23.10.13	Bristol-Myers Posts Profit In Q3 On Sales Growth, Adj. Earnings Top View (RTTNews)
23.10.13	Bristol-Myers Posts Q3 Profit, Adj. EPS Beats Estimates; Confirms FY Profit View (RTTNews)
23.10.13	Bristol-Myers Squibb To Present Data On Rheumatoid Arthritis Assets At ACR (RTTNews)
15.10.13	Under AAAResearchReports.com Microscope: Eli Lilly & Co., Bristol-Myers Squibb Co., Allergan Inc., and Endo Health Solutions Inc. (PR Newswire)
14.10.13	Clinical Trial Results, Conference Calls, and Acquisitions - Research Report on Pfizer, UnitedHealth, Actavis, Bristol-Myers Squibb, and Quest Diagnostics (PR Newswire)
30.09.13	Drug Approvals, Trial Results, and Collaboration- Research Report on Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, AbbVie, and GSK (PR Newswire)
27.09.13	Bristol-Myers Reveals Melanoma Survival Results From Pooled Analysis Of Yervoy (RTTNews)
26.09.13	AstraZeneca, Bristol-Myers Reports Additional Results From SAVOR Trial (RTTNews)
24.09.13	Stock Movements, Quarterly Dividends and Product Recall News - Research Report on Pfizer, Johnson & Johnson, Bristol-Myers, Merck, and Abbvie (PR Newswire)
24.09.13	AstraZeneca, Bristol-Myers Reports Results From Phase III Study Of Dapagliflozin (RTTNews)
20.09.13	Issuer Ratings, Recognitions, Positive Clinical Results, and Quarterly Dividends - Research Report on Pfizer, UnitedHealth, Merck, Gilead, and Bristol-Myers (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Deutsche Bank AG: Novartis-Aktie erhält Hold
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester
22.11.24		Optimismus in Europa: So entwickelt sich der Euro STOXX 50 am Freitagnachmittag
22.11.24		Pluszeichen in Europa: STOXX 50 notiert im Plus

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Deutsche Bank AG: Novartis-Aktie erhält Hold

22.11.24

Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester